Tag:
Latest Headlines
Latest Headlines
Boehringer, pharmas turn to social gaming for online outreach
Boehringer Ingelheim wants to create a social game dubbed "Syrum" that would let players tend to virtual R&D projects and traffic in scientific talent and compounds, according to InPharm .
Tech startup cuts through social media noise for drug and device outfits
LiquidGrids's tech crawls the vast social media universe and picks up health-related conversations; the company hopes to find clients that will pay to hear what's being said.
Big Pharma and devicemakers plot careful social media moves
Major drug and device companies are abuzz about the possibilities and pratfalls of using social media, and some of the top layers in those industries weighed in during a conference discussion in Orlando this week.
Consumers to pharma: Let's be Facebook friends (or not)
Drugmakers often get a bad rap among consumers for questionable marketing practices and events like the Vioxx scandal. Yet a consumer survey shows that, at least in online circles, pharma isn't as
FDA dishes out long-awaited guidance on social media
With drug and device makers seeking rules of the social media road from regulators, the FDA quietly issued draft guidance to shed light on its thinking about a specific area of concern for pharma
Pfizer takes lead in race for social media clout
Drugmakers all over the world are boosting their campaigns on social platforms such as Facebook and Twitter, building followings in hopes of advancing certain business objectives. A new study shows
Study ranks Pfizer, Roche, peers on Facebook, Twitter
As drugmakers look to gain greater influence on social media platforms, some companies have obviously been more successful than others. A new study has ranked the social networking statuses of major
Want Europeans' attention? Use websites, not Twitter, study finds
Is social media really the bright new frontier for pharma communications? Or are consumers less interested in pharma on Facebook and Twitter than pharma marketing types would like them to be? A new
Facebook yanks URL until Mercks agree who gets it
Facebook has apologized to both Mercks for a page-rights snafu--but beyond that, it's treating the drugmakers like squabbling children. Like a parent breaking up a fight over a favorite toy, Facebook
German Merck miffed at loss of Facebook page
Who owns the Merck Facebook page? That's the subject of a new lawsuit filed by Germany's Merck KGaA , which alleges the U.S.-based Merck & Co. ( $MRK ) co-opted its address at
